Heart Disease Clinical Trials in San Francisco

Showing 21-40 of 167 trials

Improving Congenital Heart Disease Care

NCT06581484

The theory-informed digital health intervention, called as "Empower My Congenital Health (EmpowerMyCH)" aims to activate and engage ACHD patients in building confidence toward navigating the adult healthcare system. This tool is built after incorporating the theories of behavior change, gathering inputs from target patients in all stages of its design and implementation. The key features of the tool include a digital medical passport, updated congenital information, community support, and patient stories and advice. The investigators aim to test the acceptability, feasibility, efficacy, and effectiveness of the intervention.

Congenital Heart DiseaseBehavior, HealthQuality of Life+2 more

University of California, San Francisco1,000 participantsStarted Sep 2024

San Francisco, California, United States

ACTIVE_NOT_RECRUITING< 1 mile

Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

NCT05755711

Post-market, prospective, multi-center, single-arm observational study to generate real-world clinical evidence associated with coronary IVL in a population of female subjects with calcified coronary artery disease.

Coronary Artery Disease

Shockwave Medical, Inc.399 participantsStarted May 2023

Loma Linda, California, United States • Los Angeles, California, United States • San Francisco, California, United States +46 more locations

Improving Congenital Heart Disease Care

Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

Heart Disease Trials in Other Cities

Assessment of CCM in HF With Higher Ejection Fraction

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR

Gauging Outcomes of Total Milk Ingestion on Lipid and gControl

ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation

Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)

Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes

EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease

Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

SyncAV Post-Market Trial

A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2

PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

Diagnosis and Treatment of CAD in Severe PAD After Lower Extremity Revascularization

Other Conditions in San Francisco